What we do
Cardiac amyloidosis is a rare disease that often goes undetected as a cause of heart failure. Patients may present with restrictive cardiomyopathy (heart failure with preserved ejection fraction) or may show no symptoms. This condition may be sporadic, age-related or familial. Most cases are due to transthyretin (ATTR) or immunoglobulin light chain (AL) amyloidosis. Comprehensive treatments for cardiac amyloidosis are available, including new and investigational therapies.
Diagnostic services available:
-Echocardiogram with strain mapping
-Technetium pyrophosphate scan